ArticleJournal of imaging2026
Interpretable Diagnosis of Pulmonary Emphysema on Low-Dose CT Using ResNet Embeddings.
Article in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate and interpretable detection of pulmonary emphysema on low-dose computed tomography (LDCT) remains a critical challenge for large-scale screening and population health studies. This work proposes a quality-controlled and interpretable deep learning pipeline for emphysema assessment using ResNet-152 embeddings. The pipeline integrates automated lung segmentation, quality-control filtering, and extraction of 2048-dimensional embeddings from mid-lung patches, followed by analysis using logistic regression, LASSO, and recursive feature elimination (RFE). The embeddings are further fused with quantitative CT (QCT) markers, including %LAA, Perc15, and total lung volume (TLV), to enhance robustness and interpretability. Bootstrapped validation demonstrates strong diagnostic performance (ROC-AUC = 0.996, PR-AUC = 0.962, balanced accuracy = 0.931) with low computational cost. The proposed approach shows that ResNet embeddings pretrained on CT data can be effectively reused without retraining for emphysema characterization, providing a reproducible and explainable framework suitable as a research and screening-support framework for population-level LDCT analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.